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Evaluating a Depression Treatment  
Program on HIV Care and Mental Health 
Outcomes in Malawi
Among people initiating antiretroviral therapy 
(ART), those with depression are a large and 
especially vulnerable population. Depression 
affects 18–30 percent of patients receiving HIV 
care in Africa1 and is an important barrier to early 
ART retention.2,3 
The potential for depression treatment to improve 
HIV care outcomes has received little attention 
in the region, in part because of the very limited 
mental health infrastructure in many countries. 
Malawi’s Ministry of Health is working to build 
mental health capacity through task-sharing 
approaches, including training primary care 
providers and outreach workers in mental health 
screening and counseling.
Project SOAR is working with the Ministry of Health 
to implement and evaluate the integration of a 
depression management program into HIV care 
in Malawi—a country in which nearly a quarter 
of people initiating ART are lost to care within 
the first 12 months.4 The project combines two 
depression treatment models—algorithm-based 
medication management and problem-solving 
therapy—into a single program that is offered 
at two HIV clinics in Lilongwe to patients newly 
initiating antiretroviral treatment and who have 
depressive symptoms. 
This study will provide critical evidence on the 
feasibility, effectiveness, and cost-effectiveness 
of an integrated depression treatment model for 
improving retention in and adherence to HIV care. 
Such evidence has implications not only for the 
applicability of the model in Malawi but for other 
countries in sub-Saharan Africa as well. 
OUR RESEARCH 
The study employs a pre-post design over a 
15-month period. There is an initial observation 
period at both clinics during which HIV and mental 
health outcomes are being measured among 
clients initiating ART and receiving standard care. 
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This study will provide critical evidence on the feasibility, 
effectiveness, and cost-effectiveness of an integrated 
depression treatment model. Such evidence has 
implications not only for Malawi, but for other 
sub-Saharan countries as well.
health treatment program at different times. The 
study team will continue to measure HIV and 
mental health outcomes among clients initiating 
ART together with the combined mental health 
treatment program. 
We expect to abstract depression screening 
data across the two clinics for approximately 
1,830 adult patients newly initiating ART. We 
also will abstract further treatment and outcome 
data before and after the intervention for those 
patients who screen positive for mild, moderate, 
or severe depression. We will compare retention 
in HIV care, viral suppression, and depression 
response and remission among patients receiving 
the combined program compared to those 
receiving usual care.
RESEARCH UTILIZATION
The research team is engaging a range of 
stakeholders, including health facility staff and 
Ministry of Health officials, over the course of the 
study to foster research utilization. For example, 
select stakeholders will present preliminary 
findings at a data interpretation workshop 
and lead discussions on their implications for 
programs and policy. Subsequently, the research 
team, Ministry officials, and facility staff will 
develop a data use plan that will help guide the 
local dissemination agenda and target audiences.
In addition to presentations at local and regional 
conferences, all involved clinics will receive a 
formal presentation regarding program outcomes 
and proposed next steps. In coordination with 
our stakeholders and partners in the Ministry of 
Health, we will also develop presentations that 
are geared specifically to local clinics that were 
not involved in the program, transferring relevant 
information and “lessons learned” from on-the-
ground healthcare workers. Finally, through our 
identified Ministry stakeholders, we will present 
our results to the Ministry of Health HIV care and 
treatment group and the National Health Sciences 
research committee to facilitate discussion 
regarding policy implications of our findings. 
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What are the study’s outcome 
indicators?
HIV 
	Proportion of patients keeping all HIV care 
appointments required to maintain their ART 
supply through the first six months on ART 
	Proportion of patients with a HIV RNA viral 
load of <1,000 copies/mL approximately six 
months (+/- six weeks) after starting ART
Mental health 
	Proportion of patients with remission of 
depressive symptoms at six months
	Proportion of patients with a decrease of 
50 percent or more in depressive symptoms 
from baseline to six months
Cost and cost-effectiveness
	Expense associated with delivering the 
depression treatment program per patient 
and per clinic
	Cost per additional case of viral suppression 
achieved
	Cost per additional case of depression 
remission achieved
